Publications

5429 Results

A phase 1 study of triple targeted therapy with BRAF, MEK and AKT inhibitors for patients with BRAF mutated cancers

Authors
AP Algazi;J Moon;C Lao;B Chmielowski;K Kendra;K Lewis;R Gonzalez;K Kim;JE Godwin;B Curti;M Latkovic-Taber;S Lomeli;B Gufford;P Scumpia;R Lo;M Othus;A Ribas
Journal / Conference
Cancer Jan 23. doi: 10.1002/cncr.35200. Online ahead of print
Year
2024
Research Committee(s)
Melanoma
PMID
PMID38261444
Study Number(s)
S1221

Clinical Evaluation of Complete Remission (CR) with Partial Hematologic Recovery (CRh) in Acute Myeloid Leukemia: A Report of 7,235 Patients from Seven Cohorts Running head: Survival following CRh in AML

Authors
J Appelbaum;A Wei;S Mandrekar;I Tiong;C Chua;T Teh;C Fong;S Ting;D Weber;A Benner;H Hill;M Saadati;J Yin;R Stone;G Garcia-Manero;H Erba;G Yy;G Marcucci;R Larson;A Thomas;S Freeman;N Marquez Almuina;K Dohner;I Thomas;N Russel;H Dohner;M Othus;E Estey;R Walter
Journal / Conference
Leukemia Feb;38(2):389-392
Year
2024
Research Committee(s)
Leukemia
PMID
PMID38263433

CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular carcinoma

Authors
G Abou-Alfa;S Geyer;A Nixon;F Innocenti;Q Shi;S Jacobson;I El Dika;A Yaqubie;J Lopez;B Hwang;A El-Khoueiry;Y Tang;Y Wen;L Schwartz;M Bertagnolli;J Meyerhardt;E O'Reilly;A Venook
Journal / Conference
Cancer Res Commun Feb 16. doi: 10.1158/2767-9764.CRC-22-0516. Online ahead of print
Year
2024
Research Committee(s)
Gastrointestinal
PMID
PMID38363156
Study Number(s)
CTSU/C80802

Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children

Authors
A Lo;A Liu;Q Liu;Y Yasui;S Catellino;K Kelly;A Hererra;JW Friedberg;D Friedman;C Schwartz;Q Pei;S Kessel;S Bergeron-Gravel;H Dama;K Roberts;L Constine;D Hodgson
Journal / Conference
JAMA Network Open Jan 2;7(1):e2351062
Year
2024
Research Committee(s)
Lymphoma
PMID
PMID38241048
PMC
PMC10799264
Study Number(s)
S1826

Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer

Authors
H Arai;Y Yang;J Millstein;T Denda;F Ou;F Innocenti;H Takeda;Y Kubota;A Doi;Y Horie;K Umemoto;N Izawa;J Wang;F Battaglin;P Jayachandran;S Algaze;S Soni;W Zhang;W Zhang;R Goldberg;M Hall;A Scott;J Hwang;E Lou;B Weinberg;J Marshall;S Goel;J Xiu;M Korn;A Venook;Y Sunakawa;H-J Lenz
Journal / Conference
Eur J Cancer Feb 10:201:113914. doi: 10.1016/j.ejca.2024.113914. Online ahead of print
Year
2024
Research Committee(s)
Gastrointestinal
PMID
PMID: 38359495
Study Number(s)
CTSU/C80405

Long Term Follow-up from A041202, A Phase 3 Study of Bendamustine/Rituximab vs Ibrutinib or Ibrutinib/Rituximab Shows Continued Efficacy and Safety of Ibrutinib in Older Adults with CLL

Authors
J Woyach;G Burbano;A Ruppert;C Miller;N Heerema;W Zhao;A Wall;W Ding;N Bartlett;D Brander;P Barr;K Rogers;S Parekh;D Stephens;J Brown;G Lozanski;J Blachly;S Nattam;R Larson;H Erba;M Litzow;S Lugar;C Owen;C Kuzma;J Abramson;R Little;S Dinner;R Stone;G Uy;W Stock;S Mandrekar;J Byrd
Journal / Conference
Blood Jan 12:blood.2023021959. doi: 10.1182/blood.2023021959. Online ahead of print
Year
2024
Research Committee(s)
Leukemia
PMID
PMID38215395
Study Number(s)
CTSU/A041202

Improved outcomes with 7+3 induction chemotherapy for acute myeloid leukemia over the past four decades: Analysis of SWOG trial data

Authors
M Othus;G Garcia-Manero;J Godwin;J Weick;F Appelbaum;H Erba;E Estey
Journal / Conference
Haematologica Jan 1;108(1):42-47
Year
2023
Research Committee(s)
Leukemia
PMID
PMID35833298
PMC
PMC9827148
Study Number(s)
S0106, S1203, SWOG-8600, SWOG-9031

Relevance of bone marrow biopsies for response assessment in U.S. National Cancer Institute National Clinical Trials Network follicular lymphoma clinical trials

Authors
S Rutherford;J Yin;L Pederson;G Perez Burbano;P LaPlant;M Shadman;H Li;M LeBlanc;V Kenkre;F Hong;K Blum;T Dockter;P Martin;S Jung;B Grant;C Rosenbaum;C Ujjani;P Barr;J Unger;B Cheson;N Bartlett;B Kahl;JW Friedberg;S Mandrekar;J Leonard
Journal / Conference
Journal of Clinical Oncology 10;41(2):336-342
Year
2023
Research Committee(s)
Lymphoma
PMID
PMID35787017
PMC
PMC9839232
Study Number(s)
S0016, S0801

Acquired Genomic Alterations on First Line Chemotherapy with Cetuximab/Bevacizumab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of CALGB/SWOG-80405 Trial

Authors
K Raghav;F-S Ou;A Venook;F Innocenti;R Sun;H-J Lenz;ES Kopetz
Journal / Conference
Journal of Clinical Oncology Jan 20;41(3):472-478
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID36067452
PMC
PMC9870237
Study Number(s)
CTSU/C80405

Phase III Prospectively Randomized Trial of Perioperative 5-FU after Curative Resection, Followed by 5-FU/Leucovorin for Patients with Colon Cancer- Intergroup: A trial of the ECOG-ACRIN Research Group (E1292)

Authors
MM Kemeny;F Zhao;A Forastiere;P Catalano;D Heimann;SR Hamilton;B Meidema;N Dawson;LM Weiner;B Smith;BA Mason;S Graziano;PB Gilman;A Venook;H Pinto;RP Whitehead;PJ O'Dwyer;AB Benson
Journal / Conference
Annals Surgical Oncology Feb;30(2):1099-1109
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID36305992
PMC
PMC9807536